Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Large B-Cell, Diffuse 2Carcinoma, Hepatocellular 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Pheochromocytoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma Metastatic 1Osteosarcoma 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Lymphoma 1Lung Neoplasms 1Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma 1Gynecological Cancer 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Esophageal Squamous Cell Carcinoma 1

Interventions

Oxaliplatin 6Irinotecan 5Fluorouracil 5Bevacizumab 4Leucovorin 3Drug Therapy 3Capecitabine 35,10-methylenetetrahydrofolic acid 3pembrolizumab 2Ocoxin 2Magnetic Resonance Spectroscopy 2Levoleucovorin 2Folfox protocol 2Cyclophosphamide 2Cetuximab 2trifluridine tipiracil drug combination 1sintilimab 1repotrectinib 1pralsetinib 1penpulimab 1napabucasin 1huachansu 1guadecitabine 1golotimod 1encorafenib 1alectinib 1XELOX 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1S-1 plus cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastrointestinal Diseases × penpulimab × Clear all
NCT05494060 2023-11-07

EXPLORING

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
80 enrolled
Gastrointestinal

Carcinoma, Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡